Gender difference in C-reactive protein concentrations in individuals with atherothrombotic risk factors and apparently healthy ones

References

• BALLOU, S. P. and LOZANSKI, G. 1992, Induction of inflammatory cytokine release from cultured human monocytes by C-reactive protein. Cytokine, 4, 361–368.
   PubMed Web of Science ®Google Scholar
• CERMAK, J., KEY, N. S., BACH, R. R., BALL, J., JACOB, H. S. and VERCELLOTTI, G. M. 2000, C-reactive protein induces human peripheral blood monocytes to synthesis tissue factor. Thrombosis and Haemostasis, 84, 730–731.
   PubMed Web of Science ®Google Scholar
• COHEN, S., TOLSHINSKY, T, ROGOWSKI, 0., SHAPIRA, I., LACHMI, K., HIRSCH, M., BEN ASSAYAG, E., BURKE, M., DEu-rcu, V, BERLINER, S., HALPERN, P. and SEROV, J. 2003, Real time, control adjusted evaluation of intensity of the inflammatory response. Journal of Information Technology in Healthcare, 1, 195–207.
   Google Scholar
• DEVARAJ, S., Xu, D. Y. and JIALAL, I. 2003, C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherothrombosis. Circulation, 107, 398–404.
   PubMed Web of Science ®Google Scholar
• LABARRERE, C. A., LEE, J. B., NELSON, D. R, Ai. HASSANI, M., MILLER, S. J. and Prrrs, D. E. 2002, C-reactive protein, arterial endothelial activation, and development of transplant coronary artery disease: a prospective study. Lancet, 360, 1462–1467.
   Google Scholar
• MCCONNELL, J. P., BRANTJM, E. L., BALI-MAN, K V, LAGERSTEDT, S. A., KATZMANN, J. A. and JA1.1.1b, A. S. 2002, Gender differences in C-reactive protein concentrations — confirmation with two sensitive methods. Clinical Chemistry and Laboratory Medicine, 40, 56–59.
   Google Scholar
• PASCERI, V, Wu I FRSON, J. T. and YEH, E. T. H. 2000, Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation, 102, 2165–2171.
   PubMed Web of Science ®Google Scholar
• PASCERI, V, CHENG, J. S., Wn I FRSON, J. T, YEH, E. T. and CHANG, J. 2001, Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs. Circulation, 103, 2531–2534.
   PubMed Web of Science ®Google Scholar
• PRADHAN, A. D., MANSON, J. A. E., Rossouw, J. E., SISCOVICK, D. S., MOUTON, C. P., RIFAI, N., WALLACE, R B., JACKSON, R D., PETTINGER, M. B. and RIDKER, P. M. 2002, Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease. Prospective analysis from Women's Health Initiative Observational Study. Journal of the American Medical Association, 288, 980–987.
   Google Scholar
• RIDKER, P. M. 2001, High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation, 103, 1813–1818.
   Google Scholar
• RIDKER, P. M. 2003, Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation, 107, 363–369.
   PubMed Web of Science ®Google Scholar
• RIDKER, P. M., CUSHMAN, M., STAMPFER, M. J., TRACY, R. P. and HENNEKENS, C. H. 1997, Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. New England Journal of Medicine, 336, 973–979 [published erratum in New England Journal of Medicine, 1997, 337, 356].
   Google Scholar
• RIDKER, P. M., HENNEKENS, C. H., BURING, J. E. and RIFAI, N. 2000, C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. New England Journal of Medicine, 342, 836–843.
   PubMed Web of Science ®Google Scholar
• RIDKER, P. M., RIFAI, N., ROSE, L., BURNING, J. E. and CooK, N. R. 2002, Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. New England Journal of Medicine, 347, 1557–1565.
   PubMed Web of Science ®Google Scholar
• RIFAI, N., TRACY, R P. and RIDKER, P. M. 1999, Clinical efficacy of an automated high-sensitivity C-reactive protein assay. Clinical Chemistry, 45, 2136–2141.
   PubMed Web of Science ®Google Scholar
• ROETERS VAN LENNEP, J. E., WESTERVELT), H. T, ERKELENS, D. W. and VAN DER WALL, E. E. 2002, Risk factors for coronary heart disease: implications of gender. Cardiovascular Research, 53, 538–549.
   Google Scholar
• TORZEWSKI, M., RIST, C., MORTENSEN, R. F., ZWAKA, T. P., BIENEK, M., WALTENBERGER, J., KOENIG, W, ScHwrz, G., HOMBACH, V. and TORZEWSKI, J. 2000, C-reactive protein in the arterial intima: role of C-reactive protein receptor-dependent monocyte recruitment in atherogenesis. Arteriosclerosis and Thrombosis Vascular Biology, 20, 2094–2099.
   PubMed Web of Science ®Google Scholar
• VENUGOPAL, S. K, DEVARAJ, S., YUHANNA, I., SHAUL, P. and JIALAL, I. 2002, Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells. Circulation, 106, 1439–1441.
   PubMed Web of Science ®Google Scholar
• VERMA, S., WANG, C. H., Li, S. H., DUMONT, A. S., FEDAK, P. W, BADIWALA, M. V, DHILLON, B., WEISEL, R D., Li, R K., MICKLE, D. A. and STEWART, D. J. 2002a, A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation, 106, 913–919.
   PubMed Web of Science ®Google Scholar
• VERMA, S., Li, S. H., BADIWALA, M. V, WEISEL, R D., FEDAK, P. W. M., Li, R K, DHILLON, B. and MICKLE, D. A. G. 2002b, Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenetic effects of C-reactive protein. Circulation, 105, 1890–1896.
   Google Scholar
• WANG, T. J., NAM, B. H., WILSON, P. W, WOLF, P. A., LEvy, D., Poi, J. F., D'AGosTiNo, R B. and O'DONNELL, C. J. 2002, Association of C-reactive protein with carotid atherosclerosis in men and women: the Framingham Heart Study. Arteriosclerosis and Thrombosis Vascular Biology, 22, 1662–1667.
   Google Scholar
• WENER, M. H., DAUM, P. R and MCQUILLAN, G. M. 2000, The influence of age, sex, and race on the upper reference limit of serum C-reactive protein concentration. Journal of Rheumatology, 27, 2351–2359.
   PubMed Web of Science ®Google Scholar
• WONG, N. D., Pio, J., VALENCIA, R. and THAKAL, G. 2001, Distribution of C-reactive protein and its relation to risk factors and coronary heart disease risk estimation in the National Health and Nutrition Examination Survey (NHANES) III. Preventive Cardiology, 4, 109–114.
   PubMedGoogle Scholar
• YEH, E. T. and Wn I FRSON, J. T. 2003, Coming of age of C-reactive protein: using inflammation markers in cardiology. Circulation, 107, 370–371.
   Google Scholar